Physician profile
Greg Lee Anderson
NPI 1154368801
$8,054.78
in general payments reported to CMS, 2019-2025
44 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,668 · 2020: $674 · 2021: $1,494 · 2022: $272 · 2023: $809 · 2024: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.79 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $1,404.35 | 2019 | |
| Banner Life Sciences, LLC | $900.00 | 2021 | |
| Biogen, INC. | $721.01 | 2019-2023 | Tysabri |
| Abbvie INC. | $665.50 | 2021-2024 | Botox, Ubrelvy, Qulipta |
| Teva Pharmaceuticals USA, INC. | $527.61 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $457.41 | 2019-2024 | |
| Allergan, INC. | $457.25 | 2019-2021 | |
| Ucb, INC. | $346.85 | 2019-2020 | |
| Genzyme Corporation | $308.20 | 2019-2020 | |
| Amgen INC. | $186.20 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $180.31 | 2021 | |
| Pfizer INC. | $178.56 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $177.75 | 2019-2022 | |
| Stryker Corporation | $169.38 | 2023 | Samurai |
| Alexion Pharmaceuticals, INC. | $167.45 | 2019-2020 |
Show all 41 companies
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.